Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 501–600 of 999
Deng, Y., Fu, Y., Chua, S. L., & Khoo, B. L. (2023) · Small · doi:10.1002/smll.202205904 · Cited by 22
Role of the intratumoral microbiome in tumor progression and therapeutics implications
Meng, Y., Fan, Z., Zhou, B., & Zhan, H. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189014 · Cited by 21
Maali, Y., Journo, C., Mahieux, R., & Dutartre, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02041 · Cited by 25
The gut microbiome and potential implications for early-onset colorectal cancer
Mukherji, R., & Weinberg, B. A. (2020) · Colorectal Cancer · doi:10.2217/crc-2020-0007 · Cited by 23
Immunity, immunotherapy, and rectal cancer: A clinical and translational science review
Otegbeye, E. E., Mitchem, J. B., Park, H., Chaudhuri, A. A., Kim, H. J., Mutch, M. G., & Ciorba, M. A. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.002 · Cited by 23
Gheorghe, D. N., Camen, A., Popescu, D. M., Şincar, C. D., Pitru, A. R., Ionele, C. M., Nicolae, F. M., Danilescu, C. M., Roman, A., & Florescu, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030341 · Cited by 24
“The biofilm abounded in Bacteroides fragilis and periodontal pathogens like Fusobacterium nucleatum and Peptostreptococcus stomatitis [79,80].”
BackgroundPrevalence and implications of pKs-positive Escherichia coli in colorectal cancer
de Souza, J. B., Campos, L. A. D. A., Palácio, S. B., de Castro, M. C. A. B., & Cavalcanti, I. M. F. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122462 · Cited by 22
Zechner, E. L., & Kienesberger, S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2430423 · Cited by 22
“34,36 The pks genomic island spreads in enter-obacteria by horizontal gene transfer.”
Gut microbiota in cancer initiation, development and therapy
Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19
“…bacterial biofilms primarily composed of Escherichia coli and B . fragilis that were significantly enriched in the colonic mucosa of patients with familial adenomatous polyposis (FAP), a precancerous condition associated with hereditary CRC, compared with healthy individuals (Dejea et al., 2018).”
InfluentialGenetics, genomics and clinical features of adenomatous polyposis
Joo, J. E., Viana-Errasti, J., Buchanan, D. D., & Valle, L. (2025) · Familial Cancer · doi:10.1007/s10689-025-00460-0 · Cited by 25
“FAP patients have bacterial biofilms enriched with E. coli and Bacteroides fragilis [139], followed by the demonstration that co-colonising Apc min/+ mice with pks+E. coli and enterotoxigenic Bacteroides fragilis accelerated tumouri-genesis [140].”
Han, T., Hu, X., Li, K., Zhang, D., Zhang, Y., & Li, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761113 · Cited by 21
Xing, J., Fang, Y., Zhang, W., Zhang, H., Tang, D., & Wang, D. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02738-y · Cited by 20
“Intestinal microorganisms can find a niche to invade and grow, and maybe even reproduce which initiates the formation of biofilms [4, 5, 8].”
BackgroundInfluentialBacterial DNA involvement in carcinogenesis
Yangyanqiu, W., & Han, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.996778 · Cited by 22
“This finding was similar to those of sporadic colorectal cancer patients (Dejea et al., 2018).”
Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice
Oliero, M., Hajjar, R., Cuisiniere, T., Fragoso, G., Calvé, A., & Santos, M. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1067505 · Cited by 19
“org models of pks + Escherichia coli mono-colonization (Arthur et al., 2012; Dejea et al., 2018) and colonization of ApcMin/+ mice with colibactin producing E.”
BackgroundWang, Y. X., Huang, H. B., Dong, Y. H., Li, Z., Liu, F., & Du, Y. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13175 · Cited by 19
Oxygen concentration modulates colibactin production
Bossuet‐Greif, N., Guyonnet, C., Chagneau, C. V., Tang-Fichaux, M., Pénary, M., Loubet, D., Branchu, P., Oswald, É., & Nougayrède, J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2222437 · Cited by 23
“fragilis on the colonic epithelium of colorectal 261 cancer patients (50).”
BackgroundPossible Role of Dysbiosis of the Gut Microbiome in SLE
Kalayci, F. N. C., & Özen, S. (2023) · Current Rheumatology Reports · doi:10.1007/s11926-023-01115-8 · Cited by 22
“…by a shift from a healthy homeostasis to a disease state [50, 51] and has been implicated in autoimmune conditions [43, 52], cancers [53, 54], cardiovascular diseases [55, 56], metabolic disorders [57], obesity [58, 59], allergy [60, 61], chronic inflammations [62], neurological…”
Bacterial small molecule metabolites implicated in gastrointestinal cancer development
Turocy, T., & Crawford, J. M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01103-4 · Cited by 24
A stimuli-responsive anticancer drug delivery system with inherent antibacterial activities
Dey, S., Patel, A., Raina, K., Pradhan, N., Biswas, O., Thummer, R. P., & Manna, D. (2020) · Chemical Communications · doi:10.1039/c9cc08834b · Cited by 19
Tong, M. H., Xu, J., Li, W., Jiang, K., Yang, Y., Chen, Z., Jiao, X., Meng, X., Wang, M., Hong, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53149-w · Cited by 20
“Enterotoxigenic Bacteroides fragilis (ETBF) is strongly associated with the development of in fl ammatory bowel disease (IBD) and colorectal cancer (CRC) 7 – 9 .”
Jin, Y., Liu, H., Wang, Y., Zhang, R., Wang, Q., Wang, Y., Cui, H., Wang, X., & Bian, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119096 · Cited by 25
François, R. M. M., Massicard, J.-M., & Weissman, K. J. (2025) · Natural Product Reports · doi:10.1039/d4np00046c · Cited by 19
The specificity and structure of DNA cross-linking by the gut bacterial genotoxin colibactin
Carlson, E. S., Haslecker, R., Lecchi, C., Ramos, M. A. A., Vennelakanti, V., Honaker, L., Stornetta, A., Millán, E. S., Johnson, B. A., Kulik, H. J., et al. (2025) · Science · doi:10.1126/science.ady3571 · Cited by 18
Pierce, J. V., Fellows, J. D., Anderson, D. E., & Bernstein, H. D. (2020) · Molecular Microbiology · doi:10.1111/mmi.14616 · Cited by 20
“Production of this protein causes diarrheal disease and is associated with an increased risk of colon cancer (Dejea et al., 2018; Myers et al., 1987; Sears et al., 2008; Wu et al., 2009).”
BackgroundDiMaio, D., Emu, B., Goodman, A. L., Mothes, W., & Justice, A. C. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab212 · Cited by 24
Bacterial infections in cancer: A bilateral relationship
Basu, A., Singh, R., & Gupta, S. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1771 · Cited by 21
The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer
Guo, Q., Qin, H., Liu, X., Zhang, X., Chen, Z., Qin, T., Chang, L., & Zhang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915047 · Cited by 25
Gong, D., Adomako-Bonsu, A. G., Wang, M., & Li, J. (2023) · PeerJ · doi:10.7717/peerj.15777 · Cited by 21
“coli with the pks gene has been observed in IBD, familial adenomatous polyposis (FAP), and CRC patients, compared to healthy individuals (Dejea et al., 2018; Iwasaki et al., 2022; Gaab et al., 2023).”
BackgroundResultThe next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
Ding, K., Mou, P., Wang, Z., Liu, S., Liu, J., Lü, H., & Yu, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298524 · Cited by 25
Nontoxigenic Bacteroides fragilis: A double-edged sword
Huang, Y., Cao, J., Zhu, M., Wang, Z., Jin, Z., & Xiong, Z. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127796 · Cited by 25
Berry chemoprevention: Do berries decrease the window of opportunity for tumorigenesis
May, S., Parry, C., & Parry, L. (2020) · Food Frontiers · doi:10.1002/fft2.32 · Cited by 18
“B. Fragilis, along with F. nucleatum and E. coli can create a tumorigenic biofilm that facilitates bacterial epithelial infiltration, recruits immune cells, and promotes inflammation in precancerous colonic lesions (Dejea et al., 2018).”
BackgroundMcCoy, C. S., Mannion, A. J., Feng, Y., Madden, C. M., Artim, S. C., Au, G. G., Dolan, M., Haupt, J. L., Burns, M. A., Sheh, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80000-1 · Cited by 18
Sogari, A., Rovera, E., Grasso, G., Mariella, E., Reilly, N. M., Lamba, S., Mauri, G., Durinikova, E., Vitiello, P. P., Lorenzato, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101376 · Cited by 17
“15,16 Among these, colibactin has been widely studied for its consolidated association with CRC.”
BackgroundIntratumoral Fusobacterium nucleatum in Pancreatic Cancer: Current and Future Perspectives
D’Antonio, D. L., Zenoniani, A., Umme, S., Piattelli, A., & Curia, M. C. (2024) · Pathogens · doi:10.3390/pathogens14010002 · Cited by 24
“The status of mutation of KRAS and TP53, the unstable microsatellite, and the epigenetic dysregulation, which remain undiscussed but relevant [161], can have an impact on the tumoral charge of Fn [162].”
Masaadeh, A. H., ELETREBI, M. M., Parajuli, B., Jager, N. D., & Bosch, D. E. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2479774 · Cited by 19
“Adenomas in familial adenoma-tous polyposis syndrome are frequently associated with pks+ E. coli and ETBF, as measured with in situ hybridization and PCR. 23 In support of a causative and potentially synergistic role for these bacteria in carcinogenesis, the cocolonization of mice with both pks+ E. coli and ETBF incre…”
InfluentialDietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
Ibragimova, S., Ramachandran, R., Ali, F. R., Lipovich, L., & Ho, S. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725821 · Cited by 19
Microbial Biomarkers for Lung Cancer: Current Understandings and Limitations
Huang, J., & Huang, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247298 · Cited by 23
“Biofilm can potentially damage epithelial layers, leading to further bacterial invasion, DNA damage and chronic inflammation [94].”
BackgroundGuo, Y.-C., Ouyang, Z., He, W., Zhang, J., Qin, Q., Jiao, M., Muyldermans, S., Zheng, F., & Wen, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1065274 · Cited by 22
“coli and ETBF can increase colon tumor onset and mortality in Azoxymethane (AOM) mice (6).”
BackgroundLi, H., Sheng, D., Jin, C., Zhao, G., & Zhang, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1224705 · Cited by 22
Dzierozynski, L. N., Queen, J., & Sears, C. L. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.007 · Cited by 19
Self-citationBleich, R. M., Li, C., Sun, S., Ahn, J.-H., Dogan, B., Barlogio, C. J., Broberg, C. A., Franks, A., Bulik‐Sullivan, E. C., Carroll, I. M., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01710-y · Cited by 22
“Additionally, IBD patients with longstanding inflammation experience a greater risk of developing inflammation-associated colorectal cancer (CRC) [2–4].”
BackgroundWang, Z., Li, Z., Wang, H., Wu, Q., & Geng, Y. (2024) · Foods · doi:10.3390/foods13193183 · Cited by 21
“It induces the production of IL-17 in the colon, increases the secretion of inflammatory factors, and triggers intestinal cancer [71].”
BackgroundSelf-citationGlymenaki, M., Curio, S., Shrestha, S., Zhong, Q., Rushton, L., Barry, R. E., El-Bahrawy, M. A., Marchesi, J. R., Wang, Y., Gooderham, N. J., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02049-2 · Cited by 22
Volpe, M. R., Wilson, M. R., Brotherton, C. A., Winter, E. S., Johnson, S. E., & Balskus, E. P. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00069 · Cited by 19
Park, J. M., Lee, W. H., Seo, H., Oh, J. Y., Lee, D. Y., Kim, S., & Hahm, K. B. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-121 · Cited by 17
Guo, C., Kang, X., Cao, F., Yang, J. M., Xu, Y., Liu, X., Li, Y., Ma, X., & Fu, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.629021 · Cited by 17
“The incidence of CRA is more than 30% (Dejea et al., 2018).”
BackgroundEvolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli
Sadecki, P. W., Balboa, S. J., Lopez, L. R., Kedziora, K. M., Arthur, J. C., & Hicks, L. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00322 · Cited by 22
Pratt, M., Forbes, J. D., Knox, N., Domselaar, G. V., & Bernstein, C. N. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.287 · Cited by 19
Ha, W., Yang, J., & Shi, Y. (2022) · Nanoscale · doi:10.1039/d2nr02066a · Cited by 17
Wu, D., Wang, A., Bu, D., Sun, Y., Li, C., Hong, Y.-M., Zhang, S., Chen, S., Zhou, J., Zhang, T., et al. (2025) · iMeta · doi:10.1002/imt2.70090 · Cited by 16
Self-citationReliable detection of Host-Microbe Signatures in cancer using PRISM
Ghaddar, B., Blaser, M. J., & De, S. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.007 · Cited by 20
Mechanistic dissection unmasks colibactin as a prevalent mutagenic driver of cancer
Berger, H., & Meyer, T. F. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.010 · Cited by 20
Tang-Fichaux, M., Branchu, P., Nougayrède, J., & Oswald, É. (2021) · Toxins · doi:10.3390/toxins13120897 · Cited by 20
“coli have been shown to enhance tumorigenesis [16,18,26,66].”
BackgroundTakenaka, I. K. T. M., Bartelli, T. F., Defelicibus, A., Sendoya, J. M., Golubicki, M., Robbio, J., Serpa, M. S., Branco, G. P., Santos, L. B. C., Claro, L. C. L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809441 · Cited by 18
“In this regard, the crosstalk between tissue mutational profiles in colorectal cancer and bacteria associated to these tumors has been well described in patients with Lynch syndrome and familial adenomatous polyposis (65, 66), as well as in sporadic CRC (67).”
BackgroundNIR-II AIEgens with Photodynamic Effect for Advanced Theranostics
Yin, S., Song, J., Liu, D., Wang, K., & Qi, J. (2022) · Molecules · doi:10.3390/molecules27196649 · Cited by 17
“Recent studies have shown a close relationship between bacteria and human cancer cells, including the promotion of cancer cell development and metastasis [105,106].”
BackgroundBaldwin-Hunter, B. L., Rozenberg, F. D., Annavajhala, M. K., Park, H., DiMango, E., Keating, C. L., Uhlemann, A., & Abrams, J. A. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.013 · Cited by 18
Kyaw, T. S., Upadhyay, V., Tolstykh, I. V., Loon, K. V., Laffan, A., Stanfield, D., Gempis, D., Kenfield, S. A., Chan, J. M., Piawah, S., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.07.011 · Cited by 18
“We examined the abundance of 12 CRC-associated bacterial species [4,6,7,50,51].”
BackgroundAn Update on Blastocystis: Possible Mechanisms of Blastocystis-Mediated Colorectal Cancer
Tocci, S., Das, S., & Sayed, I. M. (2024) · Microorganisms · doi:10.3390/microorganisms12091924 · Cited by 17
“. fragilis and colibactin-producing E. coli ), and those patients develop polyps early in life [105].”
BackgroundEscherichia coli on colorectal cancer: A two‐edged sword
Chu, J., Wu, Y., Jing, Z., Zhanbo, Q., Zefeng, W., & Han, S. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70029 · Cited by 22
“These data suggested that biofilm is not only a key factor in carcinogenesis but also is re-lated to the location of colon cancer (Dejea et al., 2014; Dejea et al., 2018).”
BackgroundSeesaha, P. K., Chen, X., Wu, X., Xu, H., Li, C., Jheengut, Y., Zhao, F., Liu, L., & Zhang, D. (2020) · Future Oncology · doi:10.2217/fon-2019-0552 · Cited by 20
Self-citationMicrobial networking in cancer: when two toxins collide
Tomkovich, S., & Jobin, C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0101-2 · Cited by 18
“One contributing factor appears to be host genetics, as FAP is driven by mutations in the tumoursuppressing adenomatous polyposis coli gene, and Apc mouse models have increased Bacteroides and Enterobacteriaceae compared with WT mice.(2) B.”
BackgroundResultInfluentialTerlouw, D., Boot, A., Ducarmon, Q. R., Nooij, S., Suerink, M., van Leerdam, M. E., van Egmond, D., Tops, C. M., Zwittink, R. D., Ruano, D., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11849-y · Cited by 15
“An enrichment of polyketide synthase ( pks ) encoding Escherichia coli in patients with colorectal cancer [1, 2] and polyposis [3] implies a potential carcinogenic effect in the large intestine.”
BackgroundBiofilms: A cause for the development of cancer: A review
Gupta, A., Bhattacharya, D., Elayaperumal, S., Sivamani, Y., Lahiri, D., & Nag, M. (2025) · The Microbe · doi:10.1016/j.microb.2025.100236 · Cited by 16
Chu, Y. L., Georgeson, P., Clendenning, M., Mahmood, K., Walker, R., Como, J., Joseland, S. L., Preston, S., Rice, T., Lynch, B. M., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105661 · Cited by 16
Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer
Cui, X., Li, C., Zhong, J., Liu, Y., Xiao, P., Liu, C., Zhao, M., & Yang, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1523584 · Cited by 17
Colorectal cancer biofilm composition reveals distinct bacterial species signature
Kushwaha, M., Dalal, N., Chaudhary, S., Ahmed, A., Makharia, G. K., Singh, A. K., & Kumar, A. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13537-8 · Cited by 17
“…supports the hypothesis that biofilm-associated bacteria, such as E. coli ( pks ⁺ ) and K. pneumoniae , may contribute to an environment that facilitates tumor progression through mechanisms such as inflammation, immune evasion, and genotoxic effects (Sadeghi et al. 2024) (Dejea et al. 2018).”
Shang, T., Zhang, R., Liu, Y., & Shi, S. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00783-4 · Cited by 21
“Consistent with this idea, Benign polyps developing early in life of patients with familial adenomatous polyposis are covered by patchy bacterial biofilms containing colibactin-pro-ducing E. coli [56], suggesting a link between early neo-plasia of the colon and tumorigenic bacteria.”
Qiao, S., Li, T.-T., Jeong, M., Chuanfa, L. I. U., Mizutani, S., Hwang, S.-M., Li, Y., Lyu, M., Nishiyama, K., Tang, Y.-A., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2025.12.003 · Cited by 18
Altered Mucosal Immune-Microbiota Interactions in Familial Adenomatous Polyposis
Noble, A., Durant, L. R., Dilke, S. M., Man, R., Martin, I., Patel, R., Hoyles, L., Pring, E. T., Latchford, A. R., Clark, S. K., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000428 · Cited by 17
“The globally altered pattern of immunity in patients with FAP might be easily exploited by the more invasive species identi fi ed in the study of Dejea et al. (15), which may be able to colonize the mucosa without inducing an abnormally strong response.”
InfluentialMa, Y., Zhang, Y., Qu, R., Zhou, X., Sun, L., Wang, K., Jiang, C., Zhang, Z., & Fu, W. (2022) · Microorganisms · doi:10.3390/microorganisms10122486 · Cited by 17
“[47] also showed that Bacteroides comprise the bulk of CRC biofilms.”
BackgroundCao, Y., Shang, F., Jin, M., Deng, S., Gu, J., Mao, F., Qin, L., Ju, W., Xue, Y., Jiang, Z., et al. (2023) · BJS Open · doi:10.1093/bjsopen/zrad105 · Cited by 16
Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance
Johnston, C. D., & Bullman, S. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.01.001 · Cited by 18
The future of cancer vaccines against colorectal cancer
Jia, W., Shen, X., Guo, Z., Cheng, X., & Zhao, R. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2341744 · Cited by 17
“Compelling candidate oncomicrobial agents for CRC, including strains of E. coli producing colibactin, strains of Bacteroides fragilis secreting B. fragilis toxin (BFT) and Fusobacterium nucleatum , have been identified [93,94].”
BackgroundEngineered bacterial therapeutics for detecting and treating CRC
Siguenza, N., Brevi, A., Zhang, J. T., Pabani, A., Bhushan, A., Das, M., Ding, Y., Hasty, J., Ghosh, P., & Zarrinpar, A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.04.001 · Cited by 19
“While pks+ E. coli is implicated in CRC tumorigenesis, nonpathogenic E. coli is regularly found in the normal gut microbiome [30 – 32].”
Ji, G., Zhao, J., Si, X., & Song, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115345 · Cited by 18
An intratumor bacteria-targeted DNA nanocarrier for multifaceted tumor microenvironment intervention
Wang, Y., Fu, X., Zhu, Y., Lin, M., Cai, R.-D., Zhu, Y., & Wu, T. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101144 · Cited by 21
Gut colonization of Bacteroides plebeius suppresses colitis-associated colon cancer development
Chen, H.-L., Hu, P.-Y., Chen, C.-S., Lin, W.-H., Hsu, D. K., Liu, F., & Meng, T. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02599-24 · Cited by 21
There was collusion: Microbes in inflammatory bowel disease
Wong, S.-Y., & Cadwell, K. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007215 · Cited by 16
“coli) that act in concert to cause colorectal cancer in a subset of patients harboring a germline mutation in the Adenomatous polyposis coli (APC) tumor suppressor gene [37].”
BackgroundAnkersen, D. V., Weimers, P., Marker, D., Johannesen, T. B., Iversen, S., Lilje, B., Kristoffersen, A. B., Saboori, S., Paridaens, K., Andersen, P. S., et al. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1829031 · Cited by 15
“[43] just recently showed that two bacteria, B.”
BackgroundPenicillin disrupts mitochondrial function and induces autophagy in colorectal cancer cell lines
Hu, F., Wu, Y. Z., Liu, C., Zhu, Y., Ye, S., Xi, Y., Cui, W., & Bu, S. (2021) · Oncology Letters · doi:10.3892/ol.2021.12952 · Cited by 17
“The proximal colon is the first location to be exposed to antibiotics and different colorectal anatomical locations determine the distribution of different advocacy flora (55).”
BackgroundWang, J., Bleich, R. M., Zarmer, S., Zhang, S., Dogan, B., Simpson, K. W., & Arthur, J. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259141 · Cited by 16
“Full-length rRNA amplicon sequencing For stool and in vitro host/microbiota samples, primers for proximal 16S (27F: AGRGTTTGATYHTGGCTCAG) and distal 23S (2241R: ACCRCCCCAGTHAAACT) were used to amplify the full-length rRNA operon (4,500bp).”
BackgroundInfluentialThe New Frontier: the Intestinal Microbiome and Surgery
Skowron, K. B., Shogan, B. D., Rubin, D. T., & Hyman, N. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3744-7 · Cited by 16
The gastric mucosal-associated microbiome in patients with gastric polyposis
Ren, R., Wang, Z., Sun, H., Gao, X., Sun, G., Peng, L., Yan, B., & Yang, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-31738-2 · Cited by 18
Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin
Metz, P., Tjan, M. J. H., Wu, S., Pervaiz, M., Hermans, S. M. A., Shettigar, A., Sears, C. L., Ritschel, T., Dutilh, B. E., & Boleij, A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00364 · Cited by 17
“These two oncogenic bacteria have been shown to synergize in vivo, creating a favorable environment for CRC development (Sears and Garrett, 2014; Dejea et al., 2018).”
BackgroundSelf-citationWestern lifestyle as a driver of dysbiosis in colorectal cancer
Foegeding, N. J., Jones, Z., & Byndloss, M. X. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049051 · Cited by 15
Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?
Zhang, J., & Sears, C. L. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab126 · Cited by 17
Self-citationZhang, H., Lee, B. J. Y., Wang, T., Xiang, X., Tan, Y., Han, Y., Bi, Y., Zhi, F., Wang, X., He, F., et al. (2025) · hLife · doi:10.1016/j.hlife.2025.04.004 · Cited by 22
“Bio fi lm formed by colibac-tin-producing E. coli and ETBF on the colon neoplasia might induce CRC, which was con fi rmed in a tumor-prone mouse model, where coinfection with the two bacteria increased DNA damage in colonic epithelial cells for tumor development [125].”
The microbial landscape of tumors: a deep dive into intratumoral microbiota
Asgharzadeh, S., Pourhajibagher, M., & Bahador, A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1542142 · Cited by 20
Intratumoral microbiota: implications for cancer progression and treatment
Xie, Z., Wu, Z., Liu, Y., Gu, Y., Niu, J., & Lv, K. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1551515 · Cited by 23
The multi-kingdom cancer microbiome
Dohlman, A. B., Pan, X., Zitvogel, L., & Iliev, I. D. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02103-7 · Cited by 19
“Meanwhile, mucosa-associated species such as pks + Escherichia coli and Candida albicans do not appear to live intra tumorally but are instead found in the tumour-associated mucosa 21,26,34 .”
InfluentialObservation of the Gut Microbiota Profile in BALB/c Mice Induced by Plasmodium yoelii 17XL Infection
Guan, W., Song, X., Yang, S., Zhu, H., Li, F., & Li, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.858897 · Cited by 15
“Another study found that genes for Bacteroides fragilis toxin encoded secreted oncotoxins correlated with colorectal cancer (Dejea et al., 2018).”
BackgroundDynamic interplay of intratumoral microbiota within the colorectal cancer microenvironment
Wu, Y., Wang, P., Zhao, X., Liu, T., Situ, B., & Zheng, L. (2023) · View · doi:10.1002/viw.20230100 · Cited by 15
Novel therapeutic targets: bifidobacterium-mediated urea cycle regulation in colorectal cancer
Nie, X., Zhang, T., Huang, X., Gu, C., Zuo, W., Fu, L., Dong, Y., & Liu, H. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09889-y · Cited by 16
“…such as Fusobacterium, toxin-producing Bacteroides fragilis, and Escherichia coli, are associated with the occurrence of colorectal adenomas and cancer due to their DNA-damaging effects and impact on immunity and gut barrier function (Dejea et al. 2018; Kostic et al. 2013; Tilg et al. 2018).”
BackgroundMolan, K., Podlesek, Z., Hodnik, V., Butala, M., Oswald, É., & Bertok, D. Ž. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.05.003 · Cited by 14
Guan, W., Yang, S., Zhao, Y., Cheng, W., Song, X., Yao, Y., Xie, Y., Du, W., & Li, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.680383 · Cited by 15
“…disease, colorectal cancer, reactive airway disease, and mood disorders (Wang et al., 2011; Arrieta et al., 2015; Komaroff, 2017; Qu et al., 2017; Dejea et al., 2018). gy | www.frontiersin.org 2 Moreover, Quigley’s study suggested that gut bacteria could impact the brain, and the microbiota has…”
BackgroundGut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
Pleguezuelos‐Manzano, C., Puschhof, J., & Clevers, H. C. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-095211 · Cited by 19
Zhang, W., Zhang, J., Liu, T., Xing, J., Zhang, H., Wang, D., & Tang, D. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04081-3 · Cited by 16
Shang, J., Guo, H., Li, J., Li, Z., Yan, Z., Wei, L.-F., Hua, Y., Lin, L., & Tian, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1001372 · Cited by 16
“fragilis may be associated with the promotion of CRA development and transformation to cancer (Dejea et al., 2018).”
BackgroundBiofilms and Benign Colonic Diseases
Songtanin, B., Peterson, C., Molehin, A. J., & NUGENT, K. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214259 · Cited by 16
Novel technologies in cfDNA analysis and potential utility in clinic
Li, J., Xu, M., Peng, J., Wang, J., Zhao, Y., Wu, W., & Lan, X. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.06.07 · Cited by 15
“Treatment of mice bearing xenografts with the antibiotic metronidazole reduced the bacterial load, cancer cell proliferation and overall tumor growth (91).”
Background
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.